Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Link to relevant study record(s)

Description of key information

Short description of key information on bioaccumulation potential result: 
Turpentine oil, alpha-pinene, beta-pinene and delta-3-carene are readily absorbed by inhalation. Only a minor part is exhaled unchanged and even less is excreted unchanged in urine, showing that they are extensively metabolised. However, they all show high affinity to adipose tissues which entails a rapid distribution in fat tissues and a long terminal half-life from blood because of a slow release from fat tissues.
Short description of key information on absorption rate:
Results demonstrate rapid penetration of pinenes not only to the first stratum corneum layers but also to viable epidermis and dermis. In an in vitro study, alpha and beta-pinene did not permeate across the skin to the acceptor medium due to large cumulation in the skin tissue. However, following immersion of young pigs and one human subject for 30 minutes in baths containing 150 mL of a pine-oil mixture, alpha and beta-pinene were detected in exhaled air within 20 minutes reaching maximum levels 50-75 minutes after start of the bath and remained detectable after 1 day.

Key value for chemical safety assessment

Bioaccumulation potential:
no bioaccumulation potential

Additional information

Turpentine: Eight male volunteers were exposed to 450 mg/m3 turpentine by inhalation (2 h, 50 W) in an exposure chamber. The mean relative uptakes of alpha-pinene, beta-pinene, and 3-carene were 62%, 66%, and 68% respectively, of the amount inhaled. Between 2% and 5% of the net uptake was excreted unchanged in the expired air after the end of exposure. The mean blood clearance 21 h after exposure (CL21h) of alpha-pinene, beta-pinene and 3-carene, were 0.8, 0.5, and 0.4 L/kg/h, respectively. The mean half lives (t1/2) of the last phase of alpha-pinene, beta-pinene, and 3-carene averaged 32, 25, and 42 h, respectively. (Filipsson et al., 1996)

Since turpentine is a lipophilic substance, it accumulates in fatty tissues. In rats, the highest concentrations of inhaled turpentine were found in the spleen, kidneys, brain, and perinephric fat (Sperling et al., 1967; Savolainen et al., 1978).

Elimination of turpentine and its metabolites is primarily through the urinary tract (Lewander and Aleguas, 1998, cited in HSDB 2003). A portion of the turpentine absorbed in industrial exposures is exhaled unchanged in expired air. The remainder is excreted in the urine as glucuronic acid conjugates (Bingham, 2001, cited in HSDB 2003).

The blood and urine monoterpene concentrations were continuously monitored from a patient attempting suicide by ingestion of 400-500 mL pine oil. The blood and urine monoterpene concentrations were continuously monitored. The data suggest that monoterpenes are poorly resorbed in the gastrointestinal tract. The resorbed portion of the hydrocarbons cumulates in the lipophilic body compartments and is slowly metabolized and then excreted by the kidneys. The main metabolic pathways are hydratation, hydroxylation, rearrangement, and acetylation (Koppel, 1981).

The toxicokinetics of alpha-pinene was studied in humans. Eight healthy males were exposed to 10, 225, or 450 mg/m3 (+)-alpha-pinene or 450 mg/m3 (-)-alpha-pinene for 2 h in an inhalation chamber while performing light work (50 watts). Average pulmonary uptake of (+)-alpha-pinene and (-)-alpha-pinene amounted to 59% of the exposure concentration. Absolute uptake increased linearly with concentration. Mean blood concentration at the end of exposure were linearly related to inhaled concentration. The terminal t1/2 of alpha-pinene from the blood 695 min for (+)-alpha-pinene and 555 min for (-)-alpha-pinene. Cumulative urinary excretion of unchanged alpha-pinene amounted to less than 0.001% of each dose. Respiratory elimination of (+)-alpha-pinene and (-)-alpha-pinene was 7.7 and 7.5% of total uptake, respectively (Falk et al., 1990; cited in HSDB 2003 and 2009a).

Similarly, the renal elimination of verbenols after experimental exposure to (+) and (-)alpha-pinene was studied in humans following exposure to 10, 225, and 450 mg/m3 terpene in an exposure chamber. The pulmonary uptake was about 60%. About 8% was eliminated unchanged in exhaled air. Depending on the exposure level, about 1%-4% of the total uptake was eliminated as cis- and trans-verbenol. Most of the verbenols were eliminated within 20 h after a 2-h exposure. The renal excretion of unchanged alpha-pinene was less than 0.001%. (Levin et al., 1992, cited in HSDB 2009a)

Both alpha- and beta-pinene are readily absorbed through the pulmonary system, the skin, and the intestines (Clayton and Clayton,1981-1982; Budavari et al., 1996; cited in HSDB, 2009a and 2009b)

Pulmonary uptake of 3-carene increased linearly with exposure, approaching 70% for 225 and 450 mg/m3 exposure levels during 2-hexposures. 3-carene persists in the blood with an extended half-life, suggesting a high affinity for adipose tissues (Falk et al., 1991).

The biotransformation of (+)-, (-)-, and (+/-)-alpha-pinenes, (-)-beta-pinene and (+)-3-carene in rabbits was investigated. The major metabolites were as follows: (-)-trans-verbenol from (+)-, (-)-, and (+/-)-alpha-pinenes; (-)-10-pinanol and (-)-1-p-menthene-7,8-diol from (-)-beta-pinene; (-)-m-mentha-4,6-dien-8-ol, 3-caren-9-ol, (-)-3-carene-9-carboxylic acid, and 3-carene-9,10-dicarboxylic acid from (+)-3-carene. (Ishida, 1981)

Dermal absorption: Results demonstrate rapid penetration of pinenes not only to the first stratum corneum layers but also to viable epidermis and dermis. In an vitro study, alpha and beta-pinene did not permeate across the skin to the acceptor medium due to large cumulation in the skin tissue (Cal et al., 2006). However, following immersion of young pigs and one human subject for 30 minutes in baths containing 150 mL of a pine-oil mixture, alpha and beta-pinene were detected in exhaled air within 20 minutes reaching maximum levels 50-75 minutes after start of the bath and remained detectable after 1 day. (Opdyke, 1979, cited in HSDB 2009)

In conclusion, bioaccumulation of these terpene hydrocarbons does not occur, since the substances are efficiently metabolised to yield oxygenated metabolites (verbenol, myrtenol and myrtenic acid) that are subsequently conjugated with glucuronic acid and excreted mainly in the urine.

HSDB (Hazardous Substances Data Bank). 2003. Turpentine. HSDB No. 204. Produced by the National Library of Medicine (NLM), Bethesda, M.D. Last updated 15 October 2003.

HSDB (Hazardous Substances Data Bank). 2009a. Alpha pinene. HSDB No. 720. Produced by the National Library of Medicine (NLM), Bethesda, M.D. Last Revision Date: 26 June 2009

HSDB (Hazardous Substances Data Bank). 2009b. beta pinene. HSDB No. 5615. Produced by the National Library of Medicine (NLM), Bethesda, M.D. Last Revision Date: 26 June 2009

Discussion on bioaccumulation potential result:

Turpentine: Eight male volunteers were exposed to 450 mg/m3 turpentine by inhalation (2 h, 50 W) in an exposure chamber. The mean relative uptakes of alpha-pinene, beta-pinene, and 3-carene were 62%, 66%, and 68% respectively, of the amount inhaled. Between 2% and 5% of the net uptake was excreted unchanged in the expired air after the end of exposure. The mean blood clearance 21 h after exposure (CL21h) of alpha-pinene, beta-pinene and 3-carene, were 0.8, 0.5, and 0.4 L/kg/h, respectively. The mean half lives (t1/2) of the last phase of alpha-pinene, beta-pinene, and 3-carene averaged 32, 25, and 42 h, respectively. (Filipsson et al., 1996)

Since turpentine is a lipophilic substance, it accumulates in fatty tissues. In rats, the highest concentrations of inhaled turpentine were found in the spleen, kidneys, brain, and perinephric fat (Sperling et al., 1967; Savolainen et al., 1978).

Elimination of turpentine and its metabolites is primarily through the urinary tract (Lewander and Aleguas, 1998, cited in HSDB 2003). A portion of the turpentine absorbed in industrial exposures is exhaled unchanged in expired air. The remainder is excreted in the urine as glucuronic acid conjugates (Bingham, 2001, cited in HSDB 2003).

The blood and urine monoterpene concentrations were continuously monitored from a patient attempting suicide by ingestion of 400-500 mL pine oil. The blood and urine monoterpene concentrations were continuously monitored. The data suggest that monoterpenes are poorly resorbed in the gastrointestinal tract. The resorbed portion of the hydrocarbons cumulates in the lipophilic body compartments and is slowly metabolized and then excreted by the kidneys. The main metabolic pathways are hydratation, hydroxylation, rearrangement, and acetylation (Koppel, 1981).

The toxicokinetics of alpha-pinene was studied in humans. Eight healthy males were exposed to 10, 225, or 450 mg/m3 (+)-alpha-pinene or 450 mg/m3 (-)-alpha-pinene for 2 h in an inhalation chamber while performing light work (50 watts). Average pulmonary uptake of (+)-alpha-pinene and (-)-alpha-pinene amounted to 59% of the exposure concentration. Absolute uptake increased linearly with concentration. Mean blood concentration at the end of exposure were linearly related to inhaled concentration. The terminal t1/2 of alpha-pinene from the blood 695 min for (+)-alpha-pinene and 555 min for (-)-alpha-pinene. Cumulative urinary excretion of unchanged alpha-pinene amounted to less than 0.001% of each dose. Respiratory elimination of (+)-alpha-pinene and (-)-alpha-pinene was 7.7 and 7.5% of total uptake, respectively (Falk et al., 1990; cited in HSDB 2003 and 2009a).

Similarly, the renal elimination of verbenols after experimental exposure to (+) and (-)alpha-pinene was studied in humans following exposure to 10, 225, and 450 mg/m3 terpene in an exposure chamber. The pulmonary uptake was about 60%. About 8% was eliminated unchanged in exhaled air. Depending on the exposure level, about 1%-4% of the total uptake was eliminated as cis- and trans-verbenol. Most of the verbenols were eliminated within 20 h after a 2-h exposure. The renal excretion of unchanged alpha-pinene was less than 0.001%. (Levin et al., 1992, cited in HSDB 2009a)

Both alpha- and beta-pinene are readily absorbed through the pulmonary system, the skin, and the intestines (Clayton and Clayton,1981-1982; Budavari et al., 1996; cited in HSDB, 2009a and 2009b)

Pulmonary uptake of 3-carene increased linearly with exposure, approaching 70% for 225 and 450 mg/m3 exposure levels during 2-h exposures. 3-carene persists in the blood with an extended half-life, suggesting a high affinity for adipose tissues (Falk et al., 1991).

The biotransformation of (+)-, (-)-, and (+/-)-alpha-pinenes, (-)-beta-pinene and (+)-3-carene in rabbits was investigated. The major metabolites were as follows: (-)-trans-verbenol from (+)-, (-)-, and (+/-)-alpha-pinenes; (-)-10-pinanol and (-)-1-p-menthene-7,8-diol from (-)-beta-pinene; (-)-m-mentha-4,6-dien-8-ol, 3-caren-9-ol, (-)-3-carene-9-carboxylic acid, and 3-carene-9,10-dicarboxylic acid from (+)-3-carene. (Ishida, 1981)

In conclusion, bioaccumulation of these terpene hydrocarbons does not occur, since the substances are efficiently metabolised to yield oxygenated metabolites (verbenol, myrtenol and myrtenic acid) that are subsequently conjugated with glucuronic acid and excreted mainly in the urine.

HSDB (Hazardous Substances Data Bank). 2003. Turpentine. HSDB No. 204. Produced by the National Library of Medicine (NLM), Bethesda, M.D. Last updated 15 October 2003.

HSDB (Hazardous Substances Data Bank). 2009a. Alpha pinene. HSDB No. 720. Produced by the National Library of Medicine (NLM), Bethesda, M.D. Last Revision Date: 26 June 2009

HSDB (Hazardous Substances Data Bank). 2009b. beta pinene. HSDB No. 5615. Produced by the National Library of Medicine (NLM), Bethesda, M.D. Last Revision Date: 26 June 2009

Discussion on absorption rate:

Skin absorption of alpha and beta-pinene were studied using human skin mounted on flow-through diffusion cells. Similarly, the elimination kinetics in the skin were analysed during 4 h following 1-h exposure. The results demonstrate rapid penetration of pinenes not only to the first stratum corneum layers but also to viable epidermis and dermis (steady-state concentrations assumed to be obtained at 1-h exposure). However, pinenes did not permeate across the skin to the acceptor medium due to large cumulation in the skin tissue. Two mechanisms of elimination process of terpenes from the SC are suggested: evaporation and slightly progressive penetration from inner layer into dermis. (Cal et al., 2006)

Following immersion of young pigs and one human subject for 30 minutes in baths containing 150 mL of a pine-oil mixture (Fichtennadel-Latschenkieferol Kneipp) in 450 L of water, alpha-pinene, beta-pinene and limonene (components of Latschenkieferol) were detected in exhaled air within 20 minutes reaching maximum levels 50-75 minutes after start of the bath and remained detectable after 1 day. (Opdyke, 1979, cited in HSDB 2009)

HSDB (Hazardous Substances Data Bank). 2009. Alpha pinene. HSDB No. 720. Produced by the National Library of Medicine (NLM), Bethesda, M.D. Last Revision Date: 26 June 2009